TITLE

Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes: A Retrospective Cohort Study

AUTHOR(S)
Della, Thomas E.; Edelsberg, John S.; Hagiwara, May; Oster, Gerry; Phillips, Lawrence S.
PUB. DATE
March 2004
SOURCE
Diabetes Care;Mar2004, Vol. 27 Issue 3, p852
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a comment on the study determining the effects of thiazolidinedione drugs on patients with type 2 diabetes. Increase risks on coronary heart disease; Control of gluose level; Analysis on the blood samples of the patients.
ACCESSION #
12421195

 

Related Articles

  • 1-YEAR CLINICAL OUTCOMES AFTER IMPLANTATION OF SIROLIMUS-ELUTING STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE AND TYPE 2 DIABETES.  // Heart;Oct2010 Supplement, pA156 

    An abstract of the article "1-Year Clinical Outcomes After Implantation of Sirolimus-Eluting Stents in Patients With Coronary Artery Disease and Type 2 Diabetes" by Han Hongya, and colleagues is presented.

  • Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease. JIE HONG; YIFEI ZHANG; SHENGHAN LAI; ANKANG LV; QING SU; YAN DONG; ZHIGUANG ZHOU; WEILI TANG; JIAJUN ZHAO; LIANQUN CUI; DAJIN ZOU; DAWANG WANG; HONG LI; CHAO LIU; GUOTING WU; JIE SHEN; DALONG ZHU; WEIQING WANG; WEIFENG SHEN; GUANG NING // Diabetes Care;May2013, Vol. 36 Issue 5, p1304 

    OBJECTIVE--The two major classes of antidiabetic drugs, sulfonylureas and metformin, may differentially affect macrovascular complications and mortality in diabetic patients. We compared the long-term effects of glipizide and metformin on the major cardiovascular events in type 2 diabetic...

  • Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes: A Retrospective Cohort Study. Karter, Andrew J.; Ahmed, Ameena T.; Liu, Jennifer; Moffet, Howard O.; Parker, Melissa M.; Ferrara, Assiamira; Selby, Joe V. // Diabetes Care;Mar2004, Vol. 27 Issue 3, p850 

    Presents a comment on the study determining the effects of thiazolidinedione drugs on patients with type 2 diabetes. Increase on the risks of coronary heart disease; Factors influencing the rise on the level of mortality rate; Survival of the patients.

  • Predictive Value of Circulating Oxidized LDL for Cardiac Events in Type 2 Diabetic Patients With Coronary Artery Disease. Shimada, Kazunori; Mokuno, Hiroshi; Matsunaga, Eriko; Miyazaki, Tetsuro; Sumiyoshi, Katsuhiko; Kume, Atsumi; Miyauchi, Katsumi; Daida, Hiroyuki // Diabetes Care;Mar2004, Vol. 27 Issue 3, p843 

    Examines the role of the oxidize LDL in the development of atherosclerosis on patients with type 2 diabetes. Increase on the risks of an acute coronary syndrome; Level of survival; Analysis on the blood samples of the patients.

  • Safety concerns cloud Type 2 diabetes treatments. Gebhart, Fred // Drug Topics;Oct2007 Supplement, Vol. 151, p6s 

    The article focuses on safety concerns regarding the treatment of Type 2 diabetes. It is forwarded that the bad news for patients with this disease came from the May 21, 2007 issue of the "New England Journal of Medicine." In this issue, a meta-analysis established that the drug rosiglitazone,...

  • Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus. Fioretto, Paola; Giaccari, Andrea; Sesti, Giorgio // Cardiovascular Diabetology;10/17/2015, Vol. 14 Issue 1, p1 

    Although antidiabetic agents have been developed to target one or more of the core defects of type 2 diabetes mellitus (T2DM), many patients do not achieve glycemic goals. Inhibition of the sodium-glucose cotransporter 2 (SGLT2) induces glycosuria, reduces glucose toxicity and improves insulin...

  • Insulin Resistance, Inflammation and Atherosclerosis. Ahmad, Jamal; Khan, Abdur Rahman // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Sep2008, Vol. 7 Issue 3, p172 

    Type 2 diabetes and obesity are major risk factors for the development of coronary artery disease (CAD), and premature atherosclerosis. Both conditions are associated with insulin resistance, oxidative stress, and inflammation. Several factors that increase the risk of cardiovascular disease...

  • Abnormal glucose regulation in patients with acute ST--elevation myocardial infarction-a cohort study on 224 patients. Knudsen, Eva C.; Seljeflot, Ingebjørg; Abdelnoor, Michael; Eritsland, Jan; Mangschau, Arild; Arnesen, Harald; Andersen, Geir Ø. // Cardiovascular Diabetology;2009, Vol. 8, p1 

    Background: A high prevalence of impaired glucose tolerance and unknown type 2-diabetes in patients with coronary heart disease and no previous diagnosis of diabetes have been reported. The aims of the present study were to investigate the prevalence of abnormal glucose regulation (AGR) 3 months...

  • Clinical briefs.  // New Zealand Doctor;2/27/2008, p19 

    This section offers clinical news briefs. Data from a British study show that patients with established coronary heart disease (CHD) should not be discouraged from taking part in vigorous exercise despite previous concerns of increased chance of an myocardial infarction (MI). A U.S. research...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics